Vistagen Therapeutics (VTGN)'s 30-day implied volatility (IV30) was 93.4% at the close on October 23, 2026, up from 81.1% the day before, against a 52-week range of 52.8% to 400.0%. Its 20-day historical volatility was 91.5%.
Data as of October 23, 2026.